Accepting new patients

Sancy Leachman, M.D., Ph.D.

Accepting new patients

  • John D. Gray Endowed Chair for Melanoma Research
  • Professor of Dermatology, School of Medicine


  • Cancer
  • Dermatology

Special focus

  • General Dermatology
  • Genetic Skin Disorders
  • Melanoma
  • Skin Cancers

Locations and contact

I see patients at

About me

Leachman Curriculum Vitae (CV)
Leachman-Cassidy Research Lab
War on Melanoma™
Melanoma Community Registry
Start Seeing Melanoma™
Knight Melanoma Program


Sancy Leachman, M.D., Ph.D., is a physician-scientist who chairs the Department of Dermatology at Oregon Health & Science University (OHSU) and is the director of the Melanoma Research Program at the OHSU Knight Cancer Institute, an NCI-designated Comprehensive Cancer Center. 

The inaugural recipient of the John D. Gray Endowed Chair in Melanoma Research and Chair of the Southwest Oncology Group Melanoma Prevention Working Group, she is a dermatologist using basic science research and state-of-the-art technology to combat skin cancer.

Her clinical interests include skin cancers, especially melanoma, pigmentary disorders that result from abnormalities of melanocytes such as vitiligo, and genetic disorders that involve the skin such as pachyonychia congenita, Cowden syndrome, and other cutaneous cancer syndromes. In addition to seeing patients with pigmentary disorders, she sees general dermatology patients at the Center for Health & Healing, the Lake Oswego dermatology clinic and in our multidisciplinary melanoma clinic.

Dr. Leachman’s research interest (Leachman-Cassidy Lab) is in the prevention, early detection and chemoprevention of melanoma, particularly in genetically predisposed melanoma families. One arm of her research program examines the role of genetic predisposition and differential gene expression in the development of melanoma, with an emphasis on familial melanoma and other cutaneous cancer syndromes. Through collaborations with Dr. Cassidy, she seeks to develop agents that will serve as diagnostic tools, prognostic indicators or targeted agents for the prevention of melanoma.

Leachman is passionate about fighting the “War on Melanoma” and has led the effort in building one of the largest national melanoma patient registries in Oregon. In line with the OHSU Knight Cancer Institute’s focus on the early detection of cancer, Leachman and team have developed a mobile phone app, MoleMapper, which tracks moles and their change and growth over time. MoleMapper will help to gather data for melanoma research and, potentially, impact health outcomes in individuals at risk. Leachman collaborated with the AIM at Melanoma Foundation to help spearhead the world's first collaborative Melanoma Tissue Bank Consortium, collecting fresh-frozen primary melanoma tissue samples for use in research. Dr. Leachman and team also launched the Start Seeing Melanoma™ public health outreach campaign to increase melanoma awareness and early detection education to Oregonians.

Prior to joining OHSU in 2013, Dr. Leachman was at the University of Utah, where she was director of the Melanoma and Cutaneous Oncology Program in the Huntsman Cancer Institute, a professor in the Department of Dermatology, and member of the Imaging, Diagnostics, and Therapeutics Program and the Cancer Control and Population Sciences Program.

Leachman was a key figure in developing the Melanoma and Cutaneous Oncology Program at Huntsman Cancer Institute. We are excited to have her talent in team building in Oregon to improve the care of patients in our community by bringing together researchers and physicians with an interest in melanoma and other skin cancers in order to bring knowledge and expertise from the laboratory into the clinical realm.

Leachman also worked on a DNA vaccination study to prevent and treat papillomavirus-induced squamous cell carcinoma at Yale University School of Medicine where she completed her residency training and research fellowship. Leachman was awarded the prestigious Doris Duke Clinical Scientist Development Award in 2000 and is currently an NIH R01- and Department of Defense-funded principle investigator.

Languages spoken

  • English

Education and training

    • B.A., 1985, University of Texas at Austin Plan II
    • M.D., Ph.D., 1993, University of Texas Southwestern Medical School
  • Residency

    • Yale-New Haven Hospital (dermatology), New Haven, CT
  • Fellowship

    • Yale University School of Medicine (cutaneous oncology), New Haven, CT
  • Certifications

    • American Board of Dermatology

Memberships and associations:

  • American Medical Association
  • American Academy of Dermatology
  • Society for Investigative Dermatology
  • Intermountain Dermatology Society
  • National Vitiligo Foundation
  • Utah Medical Association
  • Vitiligo Society
  • American Association for Cancer Research
  • American Society of Human Genetics
  • Pan American Society for Pigment Cell Research
  • Utah Society of Dermatologic Medicine and Surgery
  • Medical Dermatology Society
  • Southwest Oncology Group
  • Oregon Dermatology Society
Read faculty profile


Before scheduling your appointment, we recommend you contact your insurance company to verify that the OHSU Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any copayments, co–insurance, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with OHSU providers, your out of pocket liability may be higher. Visit the billing and insurance section of our site for more information.

Ratings and reviews

Overall: 4.9 out of 5 (31 Ratings, 15 Reviews)

The patient ratings score is an average of all responses to the question "How likely would you be to recommend this provider to your family and friends (on a scale of 0 to 10)" on our nationally-recognized NRC patient surveys.

  1. {{ item.comments[0]['comment'] }}